გამტარის წინაღობა

•Download as PPT, PDF•

1 like•1,122 views

irakharebava78

Technology Education

ქარელის რესურსცენტრის პედაგოგი [email_address] ირა ხარებავა

საგანი ფიზიკა ,[object Object],თემა გამტარის წინაღობა

აქტივობები ,[object Object],[object Object],[object Object]

საშინაო დავალება (2წთ) ,[object Object],[object Object],[object Object],[object Object],[object Object]

Viewers also liked

farcrys

Pesquisa Ibope Alvorada FM Março de 2012

fabricandoweb

FDC Ban - What's Right and What's Wrong?

Anup Soans

Metcalfe feb

James Metcalfe

Best of The Talking Village Blog (2)

Flavia Rubino | The Talking Village

梁希工业设计工071 拆装玩具

zust

Turner Lovell Overview

alanprice

Text mining and analytics v6 - p1

Dave King

Comunicare col web2.0 (Vesuviocamp 2010

Luca Spoldi

PISA-test

Grete

Millennial Mom's Eating Habits - Infographic Study

SheSpeaks Inc.

Law Uncovered - One degree many options

Brunel University Placement and Careers Centre

Delilah

darlajeffery

Individual sections development exercise #3

tykl94

Facebook VS. Twitter. A look at social demographics

Digital Surgeons

Good Old Jonas

magnhild

Lezione 7 4 2011

Council of Europe

CUF30107 Mod AA2 OHS Presentation

amcmills

India is proposing an ambitious plan to substantially raise spending on providing free drugs for India’s 1.2 billion population. But there are doubts over the plan’s implementation. India wants to spend up to 300 billion rupees ($5.4 billion), or 0.5% of gross domestic product, on procuring drugs to be distributed through governmentrun hospitals and clinics by 2017. Currently, India spends about 60 billion rupees ($1.1 billion), or 0.1% of GDP. Most government hospitals in India are overcrowded, understaffed and lack medicines and supplies. “Significant shortages in the number of doctors, nurses, paramedics and hospital beds per 1,000 population in India pose a great challenge for speedier implementation of universal healthcare in the country,” said Tapan Ray, director general of the Organisation of Pharmaceutical Producers of India, or OPPI, a lobby group for Pharma MNCs in India.

OPPI in Media